Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells.

Emerging evidence suggests that tumor-initiating cells (TICs) are the most malignant cell subpopulation in tumors because of their resistance to chemotherapy or radiation treatment. Targeting TICs may be a key innovation for cancer treatment. In this study, we found that PPARγ agonists inhibited the...

Full description

Bibliographic Details
Main Authors: Lanlan Liu, Zhaojuan Yang, Yingqian Xu, Jingyi Li, Dongxu Xu, Li Zhang, Jiabin Sun, Suhua Xia, Feiyan Zou, Yongzhong Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3758331?pdf=render

Similar Items